Top 5 Drug Type | Count |
---|---|
Small molecule drug | 11 |
Chemical drugs | 1 |
Target |
Mechanism AT III activators |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date07 Dec 2001 |
Target |
Mechanism factor Xa inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1997 |
Start Date29 Feb 2024 |
Sponsor / Collaborator |
Start Date16 May 2019 |
Sponsor / Collaborator |
Start Date12 Oct 2017 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Lidocaine/Prilocaine ( SCNA x VDCCs ) | Anesthesia More | Approved |
Acetylspiramycin ( 50S subunit ) | Bacterial Infections More | Approved |
Certoparin sodium ( factor Xa ) | Thromboembolism More | Approved |
Chlorambucil ( DNA ) | Non-Hodgkin Lymphoma More | Approved |
Fondaparinux Sodium ( AT III ) | Venous Thrombosis More | Approved |